Wendy Painter
- Infectious Diseases top 2%
- Epidemiology top 5%
- Molecular Biology
- Genetics top 10%
- Virology top 5%
- Co-authors
- George R. PainterWayne HolmanLaura J. SzewczykAlice RobertsonLawrence C. TrostBernhard LampertJim BushFiras Almazedi
- Topics
- SARS-CoV-2 and COVID-19 Research (8 papers)Respiratory viral infections research (7 papers)Cytomegalovirus and herpesvirus research (7 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Wendy Painter
18 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Infectious Diseases 703
- Epidemiology 535
- Molecular Biology 284
- Genetics 224
- Virology 182
Countries citing papers authored by Wendy Painter
This map shows the geographic impact of Wendy Painter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendy Painter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendy Painter more than expected).
Fields of papers citing papers by Wendy Painter
This network shows the impact of papers produced by Wendy Painter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendy Painter. The network helps show where Wendy Painter may publish in the future.
Co-authorship network of co-authors of Wendy Painter
This figure shows the co-authorship network connecting the top 25 collaborators of Wendy Painter. A scholar is included among the top collaborators of Wendy Painter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendy Painter. Wendy Painter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 14 | |
| 4 | 2 | |
| 5 | A phase 2a clinical trial of molnupiravir in patients with COVID-19 shows accelerated SARS-CoV-2 RNA clearance and elimination of infectious virusbreakdown → | 230 |
| 6 | Reduction in infectious sars-cov-2 in treatment study of covid-19 with molnupiravir | 9 |
| 7 | 112 | |
| 8 | Human Safety, Tolerability, and Pharmacokinetics of Molnupiravir, a Novel Broad-Spectrum Oral Antiviral Agent with Activity against SARS-CoV-2breakdown → | 274 |
| 9 | 4 | |
| 10 | 90 | |
| 11 | 124 | |
| 12 | 2 | |
| 13 | 5 | |
| 14 | 123 | |
| 15 | 2 | |
| 16 | 5 | |
| 17 | 61 | |
| 18 | 126 | |
| 19 | 1 |
About Wendy Painter
Wendy Painter is a scholar working on Virology, Infectious Diseases and Epidemiology, having authored 19 papers that have together received 1.2k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (8 papers), Respiratory viral infections research (7 papers) and Cytomegalovirus and herpesvirus research (7 papers). The work is most often cited by research in Virology (182 citations), Infectious Diseases (703 citations) and Epidemiology (535 citations). Wendy Painter has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include George R. Painter, Wayne Holman, Laura J. Szewczyk, Alice Robertson, Lawrence C. Trost, Bernhard Lampert, Jim Bush, Firas Almazedi, Merribeth J. Morin and Michael G. Natchus. Their work appears in journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.